http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03048781-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7721706e8ece0452723a26a9b9184f19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_eff819cf2f8885d4e460b7fee57e5fc9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_319eed6d6813db49e8057bdaa5e60233
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_15e409754c12e2a2feb03ae2bfec9ef7
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-91057
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6893
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-56911
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-02
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-543
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-573
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-569
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68
filingDate 2002-11-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c77213fbaf2328f906ec0d6b00d06d98
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5a1ae9a9b8a74283a8f58b0e31c3b42c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9772ed3f0435ef86998d4d8a815e4712
publicationDate 2003-06-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-03048781-A1
titleOfInvention Uses of the glycine-n-acyl transferase (gnat) for the diagnosis and therapy of inflammatory diseases and sepsis
abstract The invention relates to uses of the glycine-N-acyl transferase (GNAT) from body fluids or body tissues in human or veterinary medicine as a marker peptide for the diagnosis, the prognosis and the control of the progress of inflammations and infections and/or as a target for the therapeutic influence on the progress of inflammations and/or infections.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-4597741-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2006284389-A
priorityDate 2001-12-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1077258-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0175067-A2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127537750
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226441585
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6235
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395793
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226441586
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID26124
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135398721
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135460965
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399539
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226408122
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4911

Total number of triples: 43.